Skip to main content

Advertisement

SpringerLink
Log in

Lack of behavioral sensitization after repeated exposure to THC in mice and comparison to methamphetamine

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Recent evidence has provided support for the incentive-sensitization model of addiction, where repeated stimulation of neural reward circuits leads to a long-lasting sensitization of mesolimbic dopaminergic activity. This phenomenon has been demonstrated with many drugs of abuse, most often by measuring progressively increased activating effects of drugs on locomotor activity, thought to reflect an underlying neural sensitization. Whether cannabinoids, and in particular Δ9-tetrahydrocannabinol (THC), produce similar effects in this model is somewhat controversial, with mixed evidence in the literature.

Objectives

These experiments were conducted to determine whether behavioral sensitization could be established in mice after repeated exposure to THC. Sensitization to repeated methamphetamine treatment was used as a positive control.

Methods

The effects of acute and repeated intermittent (every 3–4 days) treatment with THC or methamphetamine on locomotor activity were determined in Institute of Cancer Research (ICR) mice. Additional experiments with THC employed a dosing regimen that increased the number of injections, controlled for behavioral tolerance, examined different aspects of behavior, and used a different species (Sprague–Dawley rats).

Results

Both methamphetamine and THC acutely increased activity. A robust dose-dependent sensitization was observed after intermittent treatment with methamphetamine but not with THC. Additionally, no evidence for behavioral sensitization to the effects of THC was found with any of the various protocols.

Conclusion

These data suggest that repeated THC treatment is less likely to produce behavioral sensitization than are other drugs of abuse. It appears that this phenomenon may only occur under very particular conditions, which raises doubts about its relevance to chronic cannabis users.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Angrist B (1994) Amphetaine psychosis: clinical variations of the syndrome. In: Cho A, Segal D (eds) Amphetamine and its analogues: psychopharmacology, toxicology and abuse. Academic, New York, pp 387–414

    Google Scholar 

  • Anthony JW, Warner LA, Kessler RC (1994) Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol 2:244–268

    Article  Google Scholar 

  • Arnold JC, Topple AN, Hunt GE, McGregor IS (1998) Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine. Eur J Pharmacol 354:9–16

    Article  PubMed  CAS  Google Scholar 

  • Bass CE, Martin BR (2000) Time course for the induction and maintenance of tolerance to delta(9)-tetrahydrocannabinol in mice. Drug Alcohol Depend 60:113–119

    Article  PubMed  CAS  Google Scholar 

  • Braida D, Iosue S, Pegorini S, Sala M (2004) Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats. Eur J Pharmacol 506:63–69

    Article  PubMed  CAS  Google Scholar 

  • Budney AJ, Moore BA, Vandrey RG, Hughes JR (2003) The time course and significance of cannabis withdrawal. J Abnorm Psychol 112:393–402

    Article  PubMed  Google Scholar 

  • Cadoni C, Pisanu A, Solinas M, Acquas E, Di Chiara G (2001) Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology (Berl) 158:259–266

    Article  CAS  Google Scholar 

  • Chaperon F, Thiebot MH (1999) Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 13:243–281

    PubMed  CAS  Google Scholar 

  • Chen J, Paredes W, Lowinson JH, Gardner EL (1990) Δ9-Tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex. Eur J Pharmacol 190:259–262

    Article  PubMed  CAS  Google Scholar 

  • Chen CY, O’Brien MS, Anthony JC (2005) Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001. Drug Alcohol Depend 79:11–22

    Article  PubMed  Google Scholar 

  • Costall B, Naylor RJ, Cannon JG, Lee T (1977) Differentiation of the dopamine mechanisms mediating stereotyped behaviour and hyperactivity in the nucleus accumbens and caudate-putamen. J Pharm Pharmacol 29:337–342

    PubMed  CAS  Google Scholar 

  • D’Amour FE, Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74–79

    Google Scholar 

  • Davis WM, Moreton JE, King WT, Pace HB (1972) Marihuana on locomotor activity: biphasic effect and tolerance development. Res Commun Chem Pathol Pharmacol 3:29–35

    PubMed  CAS  Google Scholar 

  • Ellgren M, Hurd YL, Franck J (2004) Amphetamine effects on dopamine levels and behavior following cannabinoid exposure during adolescence. Eur J Pharmacol 497:205–213

    Article  PubMed  CAS  Google Scholar 

  • Fish EW, DeBold JF, Miczek KA (2002) Repeated alcohol: behavioral sensitization and alcohol-heightened aggression in mice. Psychopharmacology (Berl) 160:39–48

    Article  CAS  Google Scholar 

  • Gardner EL (2002) Addictive potential of cannabinoids: the underlying neurobiology. Chem Phys Lipids 121:267–290

    Article  PubMed  CAS  Google Scholar 

  • Gardner EL, Paredes W, Smith D, Zukin RS (1989) Facilitation of brain stimulation reward by Δ9-tetrahydrocannabinol is mediated by an endogenous opioid mechanism. Adv Biosci 75:671–674

    CAS  Google Scholar 

  • Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW (1999) Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl) 141:395–404

    Article  CAS  Google Scholar 

  • Haney M, Hart CL, Vosburg SK, Nasser J, Bennett A, Zubaran C, Foltin RW (2004) Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology 29:158–170

    Article  PubMed  CAS  Google Scholar 

  • Hirabayashi M, Alam MR (1981) Enhancing effect of methamphetamine on ambulatory activity produced by repeated administration in mice. Pharmacol Biochem Behav 15:925–932

    Article  PubMed  CAS  Google Scholar 

  • Jackson DM, Anden NE, Dahlstrom A (1975) A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain. Psychopharmacologia 45:139–149

    Article  PubMed  CAS  Google Scholar 

  • Jones RT, Benowitz N, Bachman J (1976) Clinical studies of cannabis tolerance and dependence. Ann N Y Acad Sci 282:221–239

    Article  PubMed  CAS  Google Scholar 

  • Justinova Z, Tanda G, Redhi GH, Goldberg SR (2003) Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology (Berl) 169:135–140

    Article  CAS  Google Scholar 

  • Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 16:223–244

    Article  PubMed  CAS  Google Scholar 

  • Kalivas PW, Duffy P, White SR (1998) MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology 18:469–479

    Article  PubMed  CAS  Google Scholar 

  • Kita T, Okamoto M, Nakashima T (1992) Nicotine-induced ambulatory stimulant effect and its reverse tolerance. Yakubutsu Seishin Kodo 12:17–25

    PubMed  CAS  Google Scholar 

  • Kolb B, Gorny G, Limebeer CL, Parker LA (2006) Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats. Synapse 60:429–436

    Article  PubMed  CAS  Google Scholar 

  • Kouri EM, Pope HG Jr (2000) Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharmacol 8:483–492

    Article  PubMed  CAS  Google Scholar 

  • Kuribara H, Tadokoro S (1989) Reverse tolerance to ambulation-increasing effects of methamphetamine and morphine in 6 mouse strains. Jpn J Pharmacol 49:197–203

    PubMed  CAS  Google Scholar 

  • Lepore M, Vorel SR, Lowinson J, Gardner EL (1995) Conditioned place preference induced by Đ9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward. Life Sci 56:2073–2080

    Article  PubMed  CAS  Google Scholar 

  • Mallet P, Beninger RJ (1998) Δ9-Tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance. Life Sci 62:2431–2439

    Article  PubMed  CAS  Google Scholar 

  • Parker L, Gillies T (1995) THC-induced place and taste aversions in Lewis and Sprague–Dawley rats. Behav Neurosci 109:71–78

    Article  PubMed  CAS  Google Scholar 

  • Pijnenburg AJ, Honig WM, Van Rossum JM (1975) Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat. Psychopharmacologia 41:87–95

    Article  PubMed  CAS  Google Scholar 

  • Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396:157–198

    Article  PubMed  CAS  Google Scholar 

  • Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18:247–291

    Article  PubMed  CAS  Google Scholar 

  • Robinson TE, Berridge KC (2000) The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95(Suppl 2):S91–S117

    Article  PubMed  Google Scholar 

  • Rubino T, Vigano D, Massi P, Parolaro D (2001) The psychoactive ingredient of marijuana induces behavioural sensitization. Eur J Neurosci 14:884–886

    Article  PubMed  CAS  Google Scholar 

  • Rubino T, Vigano D, Massi P, Parolaro D (2003) Cellular mechanisms of Delta9-tetrahydrocannabinol behavioural sensitization. Eur J Neurosci 17:325–330

    Article  PubMed  CAS  Google Scholar 

  • SAMHSA (2002) National survey on drug use and health. Office of Applied Statistics, Rockville, MD, USA

    Google Scholar 

  • Sanudo-Pena MC, Romero J, Seale GE, Fernandez-Ruiz JJ, Walker JM (2000) Activational role of cannabinoids on movement. Eur J Pharmacol 391:269–274

    Article  PubMed  CAS  Google Scholar 

  • Sax KW, Strakowski SM (2001) Behavioral sensitization in humans. J Addict Dis 20:55–65

    Article  PubMed  CAS  Google Scholar 

  • Segal DS, Geyer MA, Schuckit MA (1981) Stimulant-induced psychosis: an evaluation of animal methods. Essays Neurochem Neuropharmacol 5:95–129

    PubMed  CAS  Google Scholar 

  • Shi LH, Luo F, Woodward DJ, Chang JY (2005) Dose and behavioral context dependent inhibition of movement and basal ganglia neural activity by Delta-9-tetrahydrocannabinol during spontaneous and treadmill locomotion tasks in rats. Synapse 55:1–16

    Article  PubMed  CAS  Google Scholar 

  • Stewart J, Badiani A (1993) Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 4:289–312

    PubMed  CAS  Google Scholar 

  • Tanda G, Goldberg SR (2003) Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a review of recent preclinical data. Psychopharmacology (Berl) 169:115–134

    Article  CAS  Google Scholar 

  • Tanda G, Pontieri F, Chiara G (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common μ1 opioid receptor mechanism. Science 276:2048–2050

    Article  PubMed  CAS  Google Scholar 

  • Tanda G, Munzar P, Goldberg SR (2000) Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci 3:1073–1074

    Article  PubMed  CAS  Google Scholar 

  • Valjent E, Maldonado R (2000) A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. Psychopharmacology (Berl) 147:436–438

    Article  CAS  Google Scholar 

  • Varvel SA, Anum E, Niyuhire F, Wise LE, Lichtman AH (2005) Delta (9)-THC-induced cognitive deficits in mice are reversed by the GABA(A) antagonist bicuculline. Psychopharmacology 178:317–327

    Article  PubMed  CAS  Google Scholar 

  • Xu X, Domino EF (1994) Phencyclidine-induced behavioral sensitization. Pharmacol Biochem Behav 47:603–608

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by NIDA grants DA-002396, DA-015683, and DA-03672.

Author information

Authors and Affiliations

  1. Department of Pharmacology and Toxicology, Virginia Commonwealth University, P.O. Box 980613, Richmond, VA, 23298-0613, USA

    Stephen A. Varvel, Billy R. Martin & Aron H. Lichtman

Authors
  1. Stephen A. Varvel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Billy R. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aron H. Lichtman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen A. Varvel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Varvel, S.A., Martin, B.R. & Lichtman, A.H. Lack of behavioral sensitization after repeated exposure to THC in mice and comparison to methamphetamine. Psychopharmacology 193, 511–519 (2007). https://doi.org/10.1007/s00213-007-0811-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-007-0811-2

Keywords

Search

Navigation